Peroxitech Inc.

Facts

as of Nov 17, 2026

Peroxitech is a privately held emerging biopharmaceutical company focused on the development and commercialization of a novel peptide for treating acute lung injury.

Headquarters
Philadelphia, United States
Employees
1-10estimated range
Website
peroxitech.com

These are the key facts about Peroxitech Inc. on Alion as of Nov 17, 2026. Peroxitech Inc. is headquartered in Philadelphia, United States. The latest round is Series A of $25M, announced in 2022.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
Philadelphia United StatesHeadquarters0
Source: office addresses in postings and company registers

Financials

Funding rounds, investors and revenue on record.

$25MTotal raised
$600kPublic grants2 public grants
Series ALatest round
3Rounds and grants
Money by yearUSD, rounds and grants
2022$25.3M2 records
2020$300k1 record
Largest rounds and grants
$25M
2022
$300k
2020
$300k
Sources: funding announcements, grant and company registers

Milestones

Dec 13, 2022
Raised a round Series A $25M
Apr 20, 2022
Won a grant $300k · CORDIS
Each milestone is dated by its source: registers, filings, the press

Newsroom

top 7%Web presenceof 133.2M domains by links, Common Crawl
Sources: the outlets named on each headline, each story once